Company / Current Assets per Share
Dyne Therapeutics, Inc. Current Assets per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.44
FY2024
5-year range
$2.10 / $24.25
FY2020-FY2024
Trend
+206.1%
vs FY2023
Sector context
#115 of 212
Health Care
What the data says
Current Assets per Share changed +206% YoY in FY2024, a notable deviation from the 5-year average annual change of +69%.
Based on SEC 10-K filings.
6.44 in FY2024 with a 5-year CAGR of +1.3%.
Improved from $4.77 to $6.44 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Sector benchmark
#115 of 212 in Health CareTop 54% of 212This company $6.44 Sector average $133.20
▼
-95.2% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 206.1% year-over-year.
- Ranks #115 out of 212 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.44 | +206.1% |
| FY2023 | $2.10 | -55.9% |
| FY2022 | $4.77 | -36.5% |
| FY2021 | $7.51 | -69.0% |
| FY2020 | $24.25 | +301.4% |
| FY2019 | $6.04 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026